Patents Assigned to MAXIGEN BIOTECH INC.
  • Patent number: 8962037
    Abstract: The present invention discloses a method of manufacturing pure dicalcium phosphate ceramics or dicalcium phosphate/hydroxyapaite (HA) biphasic ceramics for medical applications in hard tissue areas to be used as implant materials. These ceramic implant materials are in granular form or in block form, and are prepared by using an acidic phosphate compound, a basic calcium phosphate compound comprising HA, and water. The dicalcium phosphate ceramic comprises either dicalcium phosphate dihydrate (CaHPO4.2H2O, DCPD) or dicalcium anhydrous (CaHPO4, DCPA). Wherein, when the acidic phosphate compound is provided in an amount stoichiometrically equal to or in excess relative to the basic calcium phosphate compound, a reaction product is the DCPD or DCPA ceramic; when the acidic phosphate compound is provided in the amount stoichiometrically less than the basic calcium phosphate compound, the reaction product is the DCPD/HA or DCPA/HA biphasic ceramic.
    Type: Grant
    Filed: February 8, 2011
    Date of Patent: February 24, 2015
    Assignee: Maxigen Biotech Inc.
    Inventors: Sung-Tsuen Liu, Sung-Ching Chen, Hui-Chun Lai, Wan-Ting Huang
  • Patent number: 8414930
    Abstract: The present invention discloses a surgical cement and a manufacturing method thereof. The surgical cement comprises a cementing component selected form the group of a basic calcium phosphate consisting of tetracalcium phosphate, alpha-tricalcium phosphate, decomposed hydroxyapatite, or a combination thereof; a setting reagent selected form the group of an acidic calcium citrate consisting of monocalcium citrate, dicalcium citrate, or a combination thereof; and water; wherein a weight ratio of the cementing component and the setting reagent ranges from about 1:1 to about 8:1. The surgical cement is bioresorbable and bioactive and is useful in orthopedic, maxillofacial and dental applications. In addition, the surgical cement of this invention has a good flow character and a relatively short setting time.
    Type: Grant
    Filed: January 11, 2011
    Date of Patent: April 9, 2013
    Assignee: Maxigen Biotech Inc.
    Inventors: Sung-Tsuen Liu, Sung-Ching Chen, Hui-Chun Lai, Kehsin Chien
  • Publication number: 20120207839
    Abstract: The present invention discloses a mineralized collagen/bioceramic composite useful as a hard tissue replacement material or substitute material, comprising about 10% to 95% by weight of mineralized collagen and about 5% to 90% by weight of bioceramics, and a method of manufacturing the same. Wherein, the mineralized collagen is used as a binder for the bioceramics, such as calcium phosphate ceramics, calcium sulfate ceramics, calcium carbonate ceramics, and other biocompatible ceramics. The bioceramic used in the mineralized collagen/bioceramic composite can be either in powder form or in granular form.
    Type: Application
    Filed: February 14, 2011
    Publication date: August 16, 2012
    Applicant: MAXIGEN BIOTECH INC.
    Inventors: SUNG-TSUEN LIU, SUNG-CHING CHEN, WAN-CHING HSU
  • Publication number: 20120201870
    Abstract: The present invention discloses a method of manufacturing pure dicalcium phosphate ceramics or dicalcium phosphate/hydroxyapaite (HA) biphasic ceramics for medical applications in hard tissue areas to be used as implant materials. These ceramic implant materials are in granular form or in block form, and are prepared by using an acidic phosphate compound, a basic calcium phosphate compound comprising HA, and water. The dicalcium phosphate ceramic comprises either dicalcium phosphate dihydrate (CaHPO4.2H2O, DCPD) or dicalcium anhydrous (CaHPO4, DCPA). Wherein, when the acidic phosphate compound is provided in an amount stoichiometrically equal to or in excess relative to the basic calcium phosphate compound, a reaction product is the DCPD or DCPA ceramic; when the acidic phosphate compound is provided in the amount stoichiometrically less than the basic calcium phosphate compound, the reaction product is the DCPD/HA or DCPA/HA biphasic ceramic.
    Type: Application
    Filed: February 8, 2011
    Publication date: August 9, 2012
    Applicant: Maxigen Biotech Inc.
    Inventors: SUNG-TSUEN LIU, SUNG-CHING CHEN, HUI-CHUN LAI, WAN-TING HUANG
  • Publication number: 20120178684
    Abstract: The present invention discloses a surgical cement and a manufacturing method thereof. The surgical cement comprises a cementing component selected form the group of a basic calcium phosphate consisting of tetracalcium phosphate, alpha-tricalcium phosphate, decomposed hydroxyapatite, or a combination thereof; a setting reagent selected form the group of an acidic calcium citrate consisting of monocalcium citrate, dicalcium citrate, or a combination thereof; and water; wherein a weight ratio of the cementing component and the setting reagent ranges from about 1:1 to about 8:1. The surgical cement is bioresorbable and bioactive and is useful in orthopedic, maxillofacial and dental applications. In addition, the surgical cement of this invention has a good flow character and a relatively short setting time.
    Type: Application
    Filed: January 11, 2011
    Publication date: July 12, 2012
    Applicant: MAXIGEN BIOTECH INC.
    Inventors: SUNG-TSUEN LIU, SUNG-CHING CHEN, HUI-CHUN LAI, KEHSIN CHIEN